Antimicrobial innovation: Combining commitment, creativity and coherence

Nature Reviews Drug Discovery

Volumn 13, Issue 10, 2014, Pages 709-710

  Van Der Meer, Jos W M ^a   Fears, Robin ^b   Davies, Dame Sally C ^c   Meulen, Volker Ter ^d,e  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b German Academy of Sciences Leopoldina   (Germany)

^c Medical Office   (United Kingdom)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e Biosciences Programme EASAC Inter Academy Partnership   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; COST MINIMIZATION ANALYSIS; DRUG INDUSTRY; DRUG RESEARCH; EUROPEAN UNION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH PROMOTION; HUMAN; INFECTION; POLITICAL PARTICIPATION; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLIC-PRIVATE PARTNERSHIP; PUBLICATION; RESEARCH PRIORITY; RESOURCE ALLOCATION; REVIEW; ANIMAL; DRUG DESIGN; MANAGEMENT;

ANIMALS; ANTI-INFECTIVE AGENTS; DRUG DESIGN; DRUG RESISTANCE, MICROBIAL; HUMANS; POLICY MAKING;

EID: 84921768436     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd4448     Document Type: Review

References (1)

1. Fears, R. & ter Meulen, V. What do we need to do to tackle antimicrobial resistance? Lancet Global Health 2, e11-e12 (2014).